High-performance invasive brain-computer interface nears clinical validation stage


According to Li, by working with Peking University First Hospital, Xuanwu Hospital Capital Medical University and Beijing Tiantan Hospital of the Capital Medical University, Neucyber Neurotech has finished five Beinao-1 implantation operations since the beginning of 2025, delivering motor and speech rehabilitation and functional substitution for individuals with spinal cord injuries, stroke, or amyotrophic lateral sclerosis.
Beinao-1 is the world's first high-throughput wireless fully implanted BCI system and is an electroencephalogram-based BCI system.
"Next, we will complete the official registered clinical trial for the Beinao-1 intelligent BCI system, continuing to advance technological optimization and application expansion, bringing hope to more patients," Li added.
- Online archive enhances public's legal awareness
- Portuguese doctor positive on seminar's outcomes
- More jobs, labor protections offered for disabled people
- Taiwan leader Lai's planned US 'transit' sparks stern warning
- In a breath of fresh air, old mines get a makeover
- BRI exchanges share healthcare expertise